Reagent Supplies

Closed Pre-Solicitation Posted

Solicitation number
NIH-CC-OPC-23-001871
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health Clinical Center intends to award a firm-fixed price purchase order to BioFire Defense for reagent supplies and tests for infectious disease panels. The estimated value exceeds $30,000. The sole source award is justified as BioFire Defense is the only vendor that can provide the specific reagents and supplies required to operate existing instrumentation and validated lab tests within the Microbiology Service of the Department of Laboratory Medicine. Interested parties may submit capability statements by December 23, 2022 to be considered for potential future competitive procurements of similar products.

There is no set-aside designation for this procurement. BioFire Defense of Salt Lake City, Utah is identified as the incumbent and potential sole source awardee. The estimated product list and quantity is provided in an attachment totaling over $30,000 for tests across infectious disease panels to be utilized over the eight month period of performance under a purchase order with no set-aside designations applied. NAICS codes relevant to diagnostic testing supplies will apply.

Notice text

This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institute of Health, Clinical Center (CC) intends to award a Firm-Fixed price purchase order to BioFire Defense, Salt Lake City, Utah 84107, on a sole source basis to procure reagent supplies for clinical patient care testing by the Microbiology Service in the Department of Laboratory Medicine (DLM). BioFire Defense is the only vendor that can provide the specific reagents and supplies required for use with already existing instrumentation within the department and already established and validated lab tests. These instruments provide rapid, efficient, and sensitive detection of nucleic acid (DNA) from clinical samples, which allows for timely identification of the presence of infectious agents and hastens treatment. As the sole developer and manufacturer of these instruments. BioFire Defense is the only vendor from which these reagents and supplies can be purchased.

The estimated product list and quantity is attached to this notice and titled – List of Supplies - 23-001871. The exact quantity of products cannot be estimated at the time of award. The government reserves the right to increase quantities pursuant to FAR 52.217-6. The eight (8) month purchase order shall not exceed the simplified acquisition threshold.

This acquisition is being conducted under the authority of the FAR Subpart 13.106-1(b)(i) allowing the Contracting Officer (CO) to solicit from one source. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Each response should include the following Business Information:

a. DUNS.

b. Company Name, address, POC, Phone and Email address

c. Current GSA Schedules or NAICS codes appropriate to this Award.

d. Type of Company (i.e., small business, 8(a), woman owned, HubZone, veteran owned, etc.) as validated in System For Award Management (SAM). All offerors must register on the SAM located at http://www.sam.gov/portal/SAM/#1

e. Capability Statement

Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Malinda Dehner, dehnerm@cc.nih.gov by the due date and time marked in this notice.

Files

File Type Posted
List of Supplies - 23-001871.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
NOTICE OF INTENT TO SOLE SOURCE for the Development of a Handheld Device for Rapid Assessment of Burn Sepsis Risk Silver Spring, Maryland, United States · NAICS 541714 — No set-aside
Notice of Intent to Sole Source – Boston Scientific Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests. Seattle, Washington 98108, United States · NAICS 325413 Veterans Integrated Service Network 20 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity